Latest News & Features
Asia-Pacific
South Korea-based Samsung has revealed plans to commit W25 trillion to pursue new technology in areas including biopharmaceuticals and artificial intelligence. 10 August 2018
Americas
Novartis and Breckenridge settled their differences over a generic version of Novartis’s cancer drug Afinitor earlier this week. 10 August 2018
Americas
Lorie Ann Morgan was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the legal section, as LSIPR reports. 10 August 2018
Americas
The US Food and Drug Administration yesterday approved the first generic drug to receive a competitive generic therapy designation. 9 August 2018
Big Pharma
A proposed change to supplementary protection certificate rules in the EU could lead to the development of less innovative medicines, according to the Irish Pharmaceutical Healthcare Association. 9 August 2018
Americas
Boehringer Ingelheim has teamed up with academic institutions and research companies in the UK to develop a long-term gene therapy for cystic fibrosis, according to a statement released on Monday, August 6. 9 August 2018
Europe
Emma Walmsley was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the business and innovation section, as LSIPR reports. 9 August 2018
Americas
The Broad Institute of MIT and Harvard and Corteva Agriscience, the agricultural division of DowDuPont, have jointly agreed to license CRISPR/Cas9 technology to the J R Simplot Company. 8 August 2018
Americas
Guy Birkenmeier, previously a partner in Baker McKenzie’s IP practice group, has joined Foley Gardere as a partner in the firm’s technology transactions and outsourcing practice. 8 August 2018
Europe
Antoine Petit was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports. 8 August 2018